Recent Research Analysts’ Ratings Changes for Labcorp (LH)

Posted by on Aug 17th, 2026

Several analysts have recently updated their ratings and price targets for Labcorp (NYSE: LH):

  • 8/10/2026 – Labcorp was given a new $355.00 price target by Mizuho.
  • 8/4/2026 – Labcorp had its price target raised by Piper Sandler from $300.00 to $309.00. They now have a “neutral” rating on the stock.
  • 8/3/2026 – Labcorp had its price target raised by JPMorgan Chase & Co. from $330.00 to $360.00. They now have an “overweight” rating on the stock.
  • 7/31/2026 – Labcorp had its price target raised by Morgan Stanley from $308.00 to $338.00. They now have an “overweight” rating on the stock.
  • 7/31/2026 – Labcorp had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $306.00 price target on the stock.
  • 7/31/2026 – Labcorp was given a new $352.00 price target by Robert W. Baird.
  • 7/31/2026 – Labcorp had its price target raised by Truist Financial Corporation from $320.00 to $350.00. They now have a “buy” rating on the stock.
  • 7/30/2026 – Labcorp had its price target raised by Barclays PLC from $290.00 to $320.00. They now have an “equal weight” rating on the stock.
  • 7/24/2026 – Labcorp was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
  • 7/13/2026 – Labcorp had its price target raised by Robert W. Baird from $335.00 to $338.00. They now have an “outperform” rating on the stock.
  • 7/13/2026 – Labcorp had its price target raised by Bank of America Corporation from $300.00 to $320.00. They now have a “buy” rating on the stock.
  • 7/12/2026 – Labcorp was upgraded by Wall Street Zen from “hold” to “buy”.

Labcorp Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be given a dividend of $0.72 per share. The ex-dividend date is Friday, August 28th. This represents a $2.88 annualized dividend and a dividend yield of 0.9%. Labcorp’s dividend payout ratio is currently 23.82%.

Insider Activity

In related news, EVP Kathryn W. Kyle sold 92 shares of the company’s stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $286.19, for a total transaction of $26,329.48. Following the sale, the executive vice president owned 3,904 shares of the company’s stock, valued at approximately $1,117,285.76. This represents a 2.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Adam H. Schechter sold 4,669 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $320.37, for a total transaction of $1,495,807.53. Following the completion of the sale, the chief executive officer owned 102,565 shares in the company, valued at $32,858,749.05. This represents a 4.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 6,681 shares of company stock valued at $2,073,617. Corporate insiders own 0.84% of the company’s stock.

Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services. The company operates a broad network of laboratories, patient service centers and specialty testing sites to deliver diagnostic information and testing solutions that support patient care, clinical decision-making and population health initiatives.

Labcorp’s core businesses encompass clinical laboratory testing and pharmaceutical development services.

See Also

Receive News & Ratings for Labcorp Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Labcorp Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.